Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor von Johns, Douglas G., Campeau, Louis-Charles, Banka, Puja, Bautmans, An, Bueters, Tjerk, Bianchi, Elisabetta, Branca, Danila, Bulger, Paul G., Crevecoeur, Inne, Ding, Fa-Xiang, Garbaccio, Robert M., Guetschow, Erik D., Guo, Yan, Ha, Sookhee N., Johnston, Jennifer M., Josien, Hubert, Kauh, Eunkyung A., Koeplinger, Kenneth A., Kuethe, Jeffrey T., Lai, Eseng, Lanning, Christine L., Lee, Anita Y.H., Li, Li, Nair, Anilkumar G., O’Neill, Edward A., Stoch, S. Aubrey, Thaisrivongs, David A., Tucker, Thomas J., Vachal, Petr, van Dyck, Kristien, Vanhoutte, Frederic P., Volckaert, Bram, Wolford, Dennis G., Xu, Andy, Zhao, Tian, Zhou, Dan, Zhou, Susan, Zhu, Xiaohong, Zokian, Hratch J., Walji, Abbas M., Wood, Harold B.

Volltext

Study on the actuation force of triangular bistable composite laminates von Attada, Phanendra Kumar, Parapparambil Muraleedharan Nair, Anilkumar, Bhairavavajjula, Nageswara Rao

Volltext

Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms von Tong, Ling, Yu, Wensheng, Chen, Lei, Selyutin, Oleg, Dwyer, Michael P, Nair, Anilkumar G, Mazzola, Robert, Kim, Jae-Hun, Sha, Deyou, Yin, Jingjun, Ruck, Rebecca T, Davies, Ian W, Hu, Bin, Zhong, Bin, Hao, Jinglai, Ji, Tao, Zan, Shuai, Liu, Rong, Agrawal, Sony, Xia, Ellen, Curry, Stephanie, McMonagle, Patricia, Bystol, Karin, Lahser, Frederick, Carr, Donna, Rokosz, Laura, Ingravallo, Paul, Chen, Shiying, Feng, Kung-I, Cartwright, Mark, Asante-Appiah, Ernest, Kozlowski, Joseph A

Volltext

MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCV von Nair, Anilkumar G., Zeng, Qingbei, Selyutin, Oleg, Rosenblum, Stuart B., Jiang, Yueheng, Yang, De-Yi, Keertikar, Kerry, Zhou, Guowei, Dwyer, Michael, Kim, Seong Heon, Shankar, Bandarpalle, Yu, Wensheng, Tong, Ling, Chen, Lei, Mazzola, Robert, Caldwell, John, Tang, Haiqun, Agrawal, Sony, Liu, Rong, Kong, Rong, Ingravallo, Paul, Xia, Ellen, Zhai, Ying, Nomeir, Amin, Asante-Appiah, Ernest, Kozlowski, Joseph A.

Volltext

Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics von Venkatraman, Srikanth, Velazquez, Francisco, Gavalas, Stephen, Wu, Wanli, Chen, Kevin X., Nair, Anilkumar G., Bennett, Frank, Huang, Yuhua, Pinto, Patrick, Jiang, Yueheng, Selyutin, Oleg, Vibulbhan, Bancha, Zeng, Qingbei, Lesburg, Charles, Duca, Jose, Heimark, Larry, Huang, Hsueh-Cheng, Agrawal, Sony, Jiang, Chuan-kui, Ferrari, Eric, Li, Cheng, Kozlowski, Joseph, Rosenblum, Stuart, Shih, Neng-Yang, Njoroge, F. George

Volltext

Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development von Nair, Anilkumar G., Zeng, Qingbei, Selyutin, Oleg, Rosenblum, Stuart B., Jiang, Yueheng, Yang, De-Yi, Keertikar, Kerry, Zhou, Guowei, Dwyer, Michael P., Kim, Seong Heon, Shankar, Bandarpalle, Yu, Wensheng, Tong, Ling, Chen, Lei, Mazzola, Robert, Caldwell, John, Tang, Haiqun, Allard, Melissa L., Buckle, Ronald N., Gauuan, Polivina Jolicia F., Holst, Christian L., Martin, Gregory S., Naicker, Kannan P., Vellekoop, Samuel, Agrawal, Sony, Liu, Rong, Kong, Rong, Ingravallo, Paul, Xia, Ellen, Zhai, Ying, Nomeir, Amin, Kozlowski, Joseph A.

Volltext

Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors von Tong, Ling, Yu, Wensheng, Coburn, Craig A., Meinke, Peter T., Nair, Anilkumar G., Dwyer, Michael P., Chen, Lei, Selyutin, Oleg, Rosenblum, Stuart B., Jiang, Yueheng, Fells, James, Hu, Bin, Zhong, Bin, Soll, Richard M., Liu, Rong, Agrawal, Sony, Xia, Ellen, Zhai, Ying, Kong, Rong, Ingravallo, Paul, Nomeir, Amin, Asante-Appiah, Ernest, Kozlowski, Joseph A.

Volltext

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles von Nair, Anilkumar G, Wong, Michael K C, Shu, Youheng, Jiang, Yueheng, Jenh, Chung-Her, Kim, Seong Heon, Yang, De-Yi, Zeng, Qingbei, Shao, Yuefei, Zawacki, Lisa Guise, Duo, Jingqi, McGuinness, Brian F, Carroll, Carolyn Diianni, Hobbs, Doug W, Shih, Neng-Yang, Rosenblum, Stuart B, Kozlowski, Joseph A

Volltext

Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity von Yu, Wensheng, Coburn, Craig A., Yang, De-Yi, Meinke, Peter T., Wong, Michael, Rosenblum, Stuart B., Chen, Kevin X., Njoroge, George F., Chen, Lei, Dwyer, Michael P., Jiang, Yueheng, Nair, Anilkumar G., Selyutin, Oleg, Tong, Ling, Zeng, Qingbei, Zhong, Bin, Ji, Tao, Hu, Bin, Agrawal, Sony, Xia, Ellen, Zhai, Ying, Liu, Rong, Kong, Rong, Ingravallo, Paul, Asante-Appiah, Ernest, Nomeir, Amin, Fells, James, Kozlowski, Joseph A.

Volltext

Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase von Venkatraman, Srikanth, Velazquez, Francisco, Gavalas, Stephen, Wu, Wanli, Chen, Kevin X., Nair, Anilkumar G., Bennett, Frank, Huang, Yuhua, Pinto, Patrick, Jiang, Yueheng, Selyutin, Oleg, Vibulbhan, Bancha, Zeng, Qingbei, Lesburg, Charles, Duca, Jose, Huang, Hsueh-Cheng, Agrawal, Sony, Jiang, Chuan-kui, Ferrari, Eric, Li, Cheng, Kozlowski, Joseph, Rosenblum, Stuart, Shih, Neng-Yang, Njoroge, F. George

Volltext

Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitors von Dwyer, Michael P., Keertikar, Kerry M., Chen, Lei, Tong, Ling, Selyutin, Oleg, Nair, Anilkumar G., Yu, Wensheng, Zhou, Guowei, Lavey, Brian J., Yang, De-Yi, Wong, Michael, Kim, Seong Heon, Coburn, Craig A., Rosenblum, Stuart B., Zeng, Qingbei, Jiang, Yueheng, Shankar, Bandarpalle B., Rizvi, Razia, Nomeir, Amin A., Liu, Rong, Agrawal, Sony, Xia, Ellen, Kong, Rong, Zhai, Ying, Ingravallo, Paul, Asante-Appiah, Ernest, Kozlowski, Joseph A.

Volltext

Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742 von Yu, Wensheng, Coburn, Craig A., Nair, Anilkumar G., Wong, Michael, Tong, Ling, Dwyer, Michael P., Hu, Bin, Zhong, Bin, Hao, Jinglai, Yang, De-Yi, Selyutin, Oleg, Jiang, Yueheng, Rosenblum, Stuart B., Kim, Seong Heon, Lavey, Brian J., Zhou, Guowei, Rizvi, Razia, Shankar, Bandarpalle B., Zeng, Qingbei, Chen, Lei, Agrawal, Sony, Carr, Donna, Rokosz, Laura, Liu, Rong, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Lahser, Fred, Asante-Appiah, Ernest, Nomeir, Amin, Kozlowski, Joseph A.

Volltext

Structure–activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitors von Tong, Ling, Yu, Wensheng, Coburn, Craig A., Chen, Lei, Selyutin, Oleg, Zeng, Qingbei, Dwyer, Michael P., Nair, Anilkumar G., Shankar, Bandarpalle B., Kim, Seong Heon, Yang, De-Yi, Rosenblum, Stuart B., Ruck, Rebecca T., Davies, Ian W., Hu, Bin, Zhong, Bin, Hao, Jinglai, Ji, Tao, Zan, Shuai, Liu, Rong, Agrawal, Sony, Carr, Donna, Curry, Stephanie, McMonagle, Patricia, Bystol, Karin, Lahser, Frederick, Ingravallo, Paul, Chen, Shiying, Asante-Appiah, Ernest, Kozlowski, Joseph A.

Volltext

Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742 von Yu, Wensheng, Coburn, Craig A., Nair, Anilkumar G., Wong, Michael, Rosenblum, Stuart B., Zhou, Guowei, Dwyer, Michael P., Tong, Ling, Hu, Bin, Zhong, Bin, Hao, Jinglai, Ji, Tao, Zan, Shuai, Kim, Seong Heon, Zeng, Qingbei, Selyutin, Oleg, Chen, Lei, Masse, Frederic, Agrawal, Sony, Liu, Rong, Xia, Ellen, Zhai, Ying, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Asante-Appiah, Ernest, Lin, Mingxiang, Kozlowski, Joseph A.

Volltext

Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742 von Yu, Wensheng, Zhou, Guowei, Coburn, Craig A., Zeng, Qingbei, Tong, Ling, Dwyer, Michael P., Hu, Bin, Zhong, Bin, Hao, Jinglai, Ji, Tao, Zan, Shuai, Chen, Lei, Mazzola, Robert, Kim, Jae-Hun, Sha, Deyou, Selyutin, Oleg, Rosenblum, Stuart B., Lavey, Brian, Nair, Anilkumar G., Heon Kim, Seong, Keertikar, Kerry M., Rokosz, Laura, Agrawal, Sony, Liu, Rong, Xia, Ellen, Zhai, Ying, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Asante-Appiah, Ernest, Chen, Shiying, Kozlowski, Joseph A.

Volltext

Discovery of potent macrocyclic HCV NS5A inhibitors von Yu, Wensheng, Vibulbhan, Bancha, Rosenblum, Stuart B., Martin, Gregory S., Vellekoop, A. Samuel, Holst, Christian L., Coburn, Craig A., Wong, Michael, Selyutin, Oleg, Ji, Tao, Zhong, Bin, Hu, Bin, Chen, Lei, Dwyer, Michael P., Jiang, Yueheng, Nair, Anilkumar G., Tong, Ling, Zeng, Qingbei, Agrawal, Sony, Carr, Donna, Rokosz, Laura, Liu, Rong, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Lahser, Fred, Asante-Appiah, Ernest, Fells, James, Kozlowski, Joseph A.

Volltext

Discovery of an irreversible HCV NS5B polymerase inhibitor von Zeng, Qingbei, Nair, Anilkumar G., Rosenblum, Stuart B., Huang, Hsueh-Cheng, Lesburg, Charles A., Jiang, Yueheng, Selyutin, Oleg, Chan, Tin-Yau, Bennett, Frank, Chen, Kevin X., Venkatraman, Srikanth, Sannigrahi, Mousumi, Velazquez, Francisco, Duca, Jose S., Gavalas, Stephen, Huang, Yuhua, Pu, Haiyan, Wang, Li, Pinto, Patrick, Vibulbhan, Bancha, Agrawal, Sony, Ferrari, Eric, Jiang, Chuan-kui, Li, Cheng, Hesk, David, Gesell, Jennifer, Sorota, Steve, Shih, Neng-Yang, Njoroge, F. George, Kozlowski, Joseph A.

Volltext

Tailoring high Na content in P2-type layered oxide cathodes via CuLi dual doping for sodium-ion batteries von Anilkumar, Ashmitha, Nair, Neeraja, Nair, Shantikumar V., Baskar, Senthilkumar

Volltext

Tailoring high Na content in P2-type layered oxide cathodes via Cu Li dual doping for sodium-ion batteries von Anilkumar, Ashmitha, Nair, Neeraja, Nair, Shantikumar V., Baskar, Senthilkumar

Volltext

Seeing the unseen: Charles Bonnet syndrome revisited von Nair, Aditya Gopinathan, Nair, Akshay Gopinathan, Shah, Bharat R., Gandhi, Rashmin Anilkumar

Volltext